Göran Ando | MD

Göran has more than 35 years of leadership and management experience in the biotech and pharmaceutical industry, with Board positions at several global companies, including currently as Chairman [...]

Richard Davis | PHD

Rick joined Nouscom in September 2020 from Johnson and Johnson Innovation where he was the Global Oncology Venture and Transaction Lead. He was Chief Executive Officer of a European clinical [...]

Maria Jose Arce Tomas | PHD

Maria joined Nouscom in 2022. Before joining, she held senior leadership positions at PharmaMar, NovoNordisk, GE Healthcare, Abbott, Norgine and GSK. In her role she establishes the [...]

Morena D’Alise | PhD

Morena has more than 15 years’ experience in Immunology. She joined Nouscom in 2016 as Senior group leader of the Immunology Department; she currently leads the Immunology team, drives company [...]

Polonca Andermann | PhD

Polonca has more than 20 years’ experience in Clinical Operations in Pharma/Biotech and CROs covering important roles of increased responsibilities and gained extensive know-how in planning and [...]

Sven Gogov | MD

Sven Gogov, MD, is an experienced global clinical development leader bringing over 15 years of pharmaceutical oncology experience and regulatory interactions to Nouscom. Sven joined Nouscom in [...]

Genghis Lloyd-Harris | MD, PhD

Genghis identifies and invests in new businesses and supports portfolio companies. He focuses on exits of venture investments via mergers and acquisitions and IPOs. Genghis’ current and past [...]

Andrew Jefferson | MBA

Andrew is an Operating Partner at Versant Ventures and has been the Chief Operating Officer at Ridgeline Discovery since 2018. Ridgeline is Versant’s Discovery Engine which creates and operates [...]

Joachim (JR) Rothe | PhD

Joachim joined LSP in 2002 and is currently a Managing Partner and co-owner of the firm. His prime focus and responsibility within LSP is to invest in unlisted securities and the general [...]